Susquehanna International Group, LLP A Tyr Pharma Inc Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$1.51 - $2.24 $22,197 - $32,928	14,700 New	14,700 $27,000
Q2 2023 Aug 11, 2023	BUY	$1.72 - $2.57 $41,968 - $62,707	24,400 New	24,400 $52,000
Q1 2022 May 16, 2022	SELL	$4.75 - $7.54 $119,700 - $190,008	-25,200 Reduced 40.38%	37,200 $199,000
Q4 2021 Feb 14, 2022	SELL	$7.29 - $9.5 $3.86 Million - $5.03 Million	-529,100 Reduced 89.45%	62,400 $466,000
Q3 2021 Nov 15, 2021	BUY	$4.22 - $12.48 $2.5 Million - $7.38 Million	591,500 New	591,500 $5.37 Million

37.1M

30.2K

3.1K

Ticker LIFE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,625,000
Market Cap $53.2M
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.